PillRx only · Tablet, Film Coated · Oral
Cyclobenzaprine
Cyclobenzaprine Hydrochloride
6 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
6 active makers
6 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
US acquisition costNADAC · per unit
Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$0.018
Latest avg · Jul 22, 2026
-2%
Since Dec 17, 2025
6
Active US suppliers
67%
Top-2 supplier share*
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
252K
Rx · 2026 Q1
10.3M
Units dispensed
+15%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it6 active · 1 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| NuCare Pharmaceuticals, Inc. | unknown | 13 | SUPPLYING |
| Proficient Rx LP | unknown | 11 | SUPPLYING |
| Northwind Health Company, LLC | unknown | 6 | SUPPLYING |
| Cipla USA Inc. | unknown | 4 | SUPPLYING |
| AvPAK | unknown | 1 | SUPPLYING |
| American Health Packaging | unknown | 1 | SUPPLYING |
| NCS HealthCare of KY, LLC dba Vangard Labs | unknown | 2 | EXITED 2027 |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.